| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hematopoietic Stem Cell Transplantation | 30 | 2020 | 2426 | 4.70 | Why? |
| Cytomegalovirus | 9 | 2019 | 600 | 2.67 | Why? |
| Cytomegalovirus Infections | 10 | 2019 | 667 | 2.31 | Why? |
| Herpesvirus 6, Human | 6 | 2019 | 162 | 1.86 | Why? |
| Ganciclovir | 3 | 2017 | 97 | 1.42 | Why? |
| Respiratory Tract Infections | 15 | 2021 | 6817 | 1.29 | Why? |
| Roseolovirus Infections | 4 | 2019 | 131 | 1.08 | Why? |
| Rhinovirus | 6 | 2018 | 979 | 1.08 | Why? |
| Bronchoalveolar Lavage Fluid | 4 | 2019 | 2309 | 1.02 | Why? |
| Picornaviridae Infections | 4 | 2018 | 544 | 1.02 | Why? |
| Respiratory Syncytial Virus Infections | 4 | 2019 | 1234 | 0.82 | Why? |
| Transplantation, Homologous | 3 | 2018 | 757 | 0.79 | Why? |
| Transplantation Conditioning | 2 | 2018 | 323 | 0.77 | Why? |
| Respirovirus Infections | 2 | 2017 | 90 | 0.75 | Why? |
| Metapneumovirus | 4 | 2016 | 465 | 0.73 | Why? |
| Respirovirus | 2 | 2016 | 122 | 0.71 | Why? |
| Inheritance Patterns | 1 | 2017 | 20 | 0.70 | Why? |
| Chromosomes, Human | 1 | 2017 | 38 | 0.69 | Why? |
| Parainfluenza Virus 3, Human | 1 | 2017 | 67 | 0.69 | Why? |
| Opportunistic Infections | 3 | 2017 | 602 | 0.68 | Why? |
| Acyclovir | 2 | 2016 | 154 | 0.64 | Why? |
| Transplant Recipients | 6 | 2019 | 4982 | 0.63 | Why? |
| Herpesviridae Infections | 2 | 2017 | 172 | 0.63 | Why? |
| Paramyxoviridae Infections | 2 | 2017 | 364 | 0.63 | Why? |
| Adenoviridae Infections | 1 | 2017 | 150 | 0.60 | Why? |
| Nasal Lavage Fluid | 1 | 2015 | 43 | 0.60 | Why? |
| DNA, Viral | 5 | 2019 | 2521 | 0.59 | Why? |
| Graft vs Host Disease | 4 | 2018 | 501 | 0.59 | Why? |
| Herpes Zoster | 2 | 2018 | 331 | 0.57 | Why? |
| Valine | 1 | 2016 | 359 | 0.57 | Why? |
| Respiratory Syncytial Virus, Human | 2 | 2021 | 846 | 0.56 | Why? |
| Viral Load | 9 | 2021 | 15850 | 0.55 | Why? |
| Respiratory Syncytial Viruses | 3 | 2015 | 612 | 0.53 | Why? |
| Immunotherapy, Adoptive | 1 | 2017 | 524 | 0.49 | Why? |
| Tissue Donors | 3 | 2019 | 1679 | 0.46 | Why? |
| BK Virus | 2 | 2017 | 135 | 0.41 | Why? |
| Virus Diseases | 5 | 2017 | 3779 | 0.38 | Why? |
| Allografts | 3 | 2017 | 761 | 0.38 | Why? |
| Ribavirin | 1 | 2016 | 1182 | 0.37 | Why? |
| Immunity | 1 | 2019 | 2651 | 0.34 | Why? |
| Cord Blood Stem Cell Transplantation | 2 | 2018 | 143 | 0.31 | Why? |
| Virus Shedding | 3 | 2018 | 5834 | 0.31 | Why? |
| T-Lymphocytes | 3 | 2017 | 6670 | 0.30 | Why? |
| Coronaviridae Infections | 1 | 2009 | 442 | 0.29 | Why? |
| Cystitis | 1 | 2004 | 45 | 0.28 | Why? |
| Wounds and Injuries | 1 | 2017 | 1708 | 0.27 | Why? |
| Oxygen Inhalation Therapy | 1 | 2017 | 3629 | 0.26 | Why? |
| Hematologic Neoplasms | 1 | 2017 | 2105 | 0.26 | Why? |
| Coronavirus | 6 | 2017 | 18339 | 0.26 | Why? |
| Liver Transplantation | 1 | 2019 | 2864 | 0.25 | Why? |
| Sepsis | 2 | 2017 | 3517 | 0.25 | Why? |
| Polyomavirus Infections | 1 | 2004 | 156 | 0.25 | Why? |
| Antiviral Agents | 9 | 2020 | 41703 | 0.23 | Why? |
| Middle Aged | 31 | 2021 | 270681 | 0.22 | Why? |
| Peripheral Blood Stem Cell Transplantation | 2 | 2018 | 86 | 0.22 | Why? |
| Young Adult | 18 | 2021 | 93724 | 0.22 | Why? |
| Viremia | 2 | 2018 | 1020 | 0.21 | Why? |
| Adult | 30 | 2021 | 244371 | 0.21 | Why? |
| Immunocompromised Host | 6 | 2019 | 5150 | 0.20 | Why? |
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 283 | 0.20 | Why? |
| Male | 33 | 2021 | 367725 | 0.20 | Why? |
| Transplantation Immunology | 1 | 2019 | 99 | 0.19 | Why? |
| Homeless Persons | 2 | 2020 | 1171 | 0.19 | Why? |
| Female | 33 | 2021 | 380317 | 0.19 | Why? |
| Interleukin-6 | 1 | 2017 | 7522 | 0.19 | Why? |
| Transplantation, Autologous | 2 | 2018 | 364 | 0.19 | Why? |
| Anti-Bacterial Agents | 2 | 2018 | 10083 | 0.19 | Why? |
| Herpesvirus 7, Human | 1 | 2018 | 18 | 0.18 | Why? |
| Proportional Hazards Models | 3 | 2017 | 6543 | 0.18 | Why? |
| Humans | 58 | 2021 | 930598 | 0.18 | Why? |
| Child | 13 | 2021 | 70012 | 0.17 | Why? |
| Neuralgia, Postherpetic | 1 | 2016 | 22 | 0.17 | Why? |
| Premedication | 1 | 2016 | 40 | 0.17 | Why? |
| Risk Factors | 12 | 2019 | 71621 | 0.17 | Why? |
| Herpes Zoster Vaccine | 1 | 2018 | 112 | 0.16 | Why? |
| Quinazolines | 1 | 2017 | 126 | 0.16 | Why? |
| Unrelated Donors | 1 | 2017 | 187 | 0.16 | Why? |
| Acetates | 1 | 2017 | 123 | 0.16 | Why? |
| Retrospective Studies | 11 | 2019 | 105322 | 0.16 | Why? |
| Intention to Treat Analysis | 1 | 2017 | 673 | 0.15 | Why? |
| Mucosal-Associated Invariant T Cells | 1 | 2017 | 170 | 0.15 | Why? |
| Washington | 4 | 2021 | 1722 | 0.15 | Why? |
| DNA | 2 | 2018 | 778 | 0.15 | Why? |
| Adolescent | 13 | 2021 | 86841 | 0.14 | Why? |
| Receptors, Antigen, T-Cell | 2 | 2017 | 760 | 0.14 | Why? |
| Lymphoma, Non-Hodgkin | 1 | 2017 | 403 | 0.13 | Why? |
| Immunotherapy | 2 | 2017 | 2421 | 0.13 | Why? |
| Herpesvirus 4, Human | 1 | 2017 | 387 | 0.13 | Why? |
| Bronchoalveolar Lavage | 1 | 2017 | 603 | 0.13 | Why? |
| Aspergillosis | 1 | 2017 | 264 | 0.13 | Why? |
| RNA, Viral | 6 | 2021 | 32276 | 0.13 | Why? |
| Probability | 1 | 2017 | 923 | 0.12 | Why? |
| Area Under Curve | 2 | 2018 | 2564 | 0.12 | Why? |
| Cohort Studies | 6 | 2019 | 36005 | 0.12 | Why? |
| Sentinel Surveillance | 1 | 2020 | 1093 | 0.12 | Why? |
| Virus Activation | 1 | 2017 | 480 | 0.12 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2017 | 572 | 0.12 | Why? |
| Coronavirus 229E, Human | 1 | 2021 | 1241 | 0.12 | Why? |
| Drug Administration Schedule | 1 | 2019 | 2324 | 0.12 | Why? |
| Hemorrhage | 1 | 2004 | 3013 | 0.12 | Why? |
| Stem Cell Transplantation | 1 | 2017 | 531 | 0.12 | Why? |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 526 | 0.12 | Why? |
| Double-Blind Method | 3 | 2018 | 5988 | 0.12 | Why? |
| Mouth | 1 | 2017 | 622 | 0.12 | Why? |
| Treatment Outcome | 7 | 2020 | 51732 | 0.12 | Why? |
| Mortality | 3 | 2017 | 7132 | 0.11 | Why? |
| Time Factors | 5 | 2020 | 31397 | 0.11 | Why? |
| Vaccination Coverage | 1 | 2021 | 1249 | 0.11 | Why? |
| Steroids | 1 | 2017 | 904 | 0.11 | Why? |
| Nasal Cavity | 1 | 2017 | 909 | 0.11 | Why? |
| Adrenal Cortex Hormones | 2 | 2020 | 6537 | 0.11 | Why? |
| Kaplan-Meier Estimate | 2 | 2017 | 4260 | 0.11 | Why? |
| Child, Preschool | 7 | 2021 | 36283 | 0.11 | Why? |
| Patient Outcome Assessment | 1 | 2015 | 707 | 0.11 | Why? |
| Adenoviridae | 1 | 2017 | 1151 | 0.11 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.10 | Why? |
| Respiratory Function Tests | 1 | 2017 | 1755 | 0.10 | Why? |
| Incidence | 4 | 2017 | 25622 | 0.10 | Why? |
| Fever of Unknown Origin | 1 | 2011 | 93 | 0.10 | Why? |
| Aged | 16 | 2021 | 215776 | 0.10 | Why? |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2017 | 877 | 0.10 | Why? |
| Influenza, Human | 3 | 2020 | 10779 | 0.10 | Why? |
| Genome, Viral | 3 | 2021 | 13157 | 0.09 | Why? |
| Prospective Studies | 6 | 2021 | 43301 | 0.09 | Why? |
| Viruses | 1 | 2021 | 2238 | 0.09 | Why? |
| Specimen Handling | 2 | 2017 | 6190 | 0.09 | Why? |
| Acute Disease | 2 | 2018 | 6029 | 0.09 | Why? |
| Pilot Projects | 1 | 2019 | 5182 | 0.08 | Why? |
| Seasons | 2 | 2019 | 4071 | 0.08 | Why? |
| Neutropenia | 1 | 2011 | 388 | 0.08 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.08 | Why? |
| Shock, Septic | 1 | 2017 | 1313 | 0.08 | Why? |
| Epithelial Cells | 1 | 2019 | 3508 | 0.08 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2015 | 1439 | 0.08 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.08 | Why? |
| Organ Transplantation | 2 | 2014 | 2616 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.08 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.08 | Why? |
| Kinetics | 3 | 2018 | 3238 | 0.07 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.07 | Why? |
| Cell- and Tissue-Based Therapy | 2 | 2020 | 422 | 0.07 | Why? |
| AIDS-Related Opportunistic Infections | 1 | 2007 | 260 | 0.07 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4545 | 0.07 | Why? |
| Neoplasms | 4 | 2020 | 17251 | 0.07 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.07 | Why? |
| Lymphocyte Count | 1 | 2016 | 4758 | 0.07 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.07 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.06 | Why? |
| Cell Line | 1 | 2019 | 12040 | 0.06 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.06 | Why? |
| Evolution, Molecular | 1 | 2017 | 3691 | 0.06 | Why? |
| Pneumonia | 1 | 2003 | 5652 | 0.06 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
| Immunity, Innate | 1 | 2021 | 6570 | 0.06 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.06 | Why? |
| Infant | 5 | 2021 | 30274 | 0.06 | Why? |
| Respiration, Artificial | 2 | 2017 | 22116 | 0.06 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.06 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2019 | 5837 | 0.06 | Why? |
| Community-Acquired Infections | 2 | 2012 | 2328 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.06 | Why? |
| Hematopoietic Stem Cells | 1 | 2004 | 321 | 0.06 | Why? |
| Orthomyxoviridae | 1 | 2010 | 1168 | 0.06 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 11367 | 0.05 | Why? |
| Leukemia | 2 | 2018 | 598 | 0.05 | Why? |
| Macaca mulatta | 1 | 2009 | 3716 | 0.05 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.05 | Why? |
| Viral Proteins | 1 | 2018 | 7370 | 0.05 | Why? |
| Anti-Infective Agents | 1 | 2011 | 1766 | 0.05 | Why? |
| Cells, Cultured | 1 | 2009 | 5835 | 0.05 | Why? |
| Longitudinal Studies | 3 | 2021 | 9893 | 0.04 | Why? |
| Measles Vaccine | 1 | 2021 | 301 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.04 | Why? |
| Berlin | 1 | 2018 | 283 | 0.04 | Why? |
| Cytokines | 1 | 2019 | 15010 | 0.04 | Why? |
| Disease Progression | 1 | 2016 | 13580 | 0.04 | Why? |
| Self Administration | 1 | 2017 | 125 | 0.04 | Why? |
| Neoplasm Grading | 1 | 2018 | 400 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Vaccines | 1 | 2015 | 3692 | 0.04 | Why? |
| Home Infusion Therapy | 1 | 2017 | 128 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 13720 | 0.04 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.04 | Why? |
| Respiratory Insufficiency | 1 | 2017 | 7301 | 0.04 | Why? |
| Communicable Diseases | 1 | 2011 | 2148 | 0.04 | Why? |
| Serum Amyloid P-Component | 1 | 2017 | 193 | 0.04 | Why? |
| Bone Marrow Transplantation | 1 | 2018 | 343 | 0.04 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| Linear Models | 1 | 2021 | 1914 | 0.03 | Why? |
| Antibiotic Prophylaxis | 1 | 2017 | 399 | 0.03 | Why? |
| Lectins, C-Type | 1 | 2017 | 405 | 0.03 | Why? |
| Epstein-Barr Virus Infections | 1 | 2018 | 366 | 0.03 | Why? |
| Critical Illness | 1 | 2017 | 17281 | 0.03 | Why? |
| Immunization, Secondary | 1 | 2021 | 1649 | 0.03 | Why? |
| Lymphoma | 1 | 2018 | 522 | 0.03 | Why? |
| Paramyxovirinae | 1 | 2012 | 49 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.03 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2020 | 1267 | 0.03 | Why? |
| Phylogeny | 2 | 2021 | 13341 | 0.03 | Why? |
| Spatio-Temporal Analysis | 1 | 2017 | 1182 | 0.03 | Why? |
| Morbidity | 1 | 2017 | 1426 | 0.03 | Why? |
| Disease Management | 2 | 2020 | 6841 | 0.03 | Why? |
| Vaccines, Inactivated | 1 | 2018 | 1562 | 0.03 | Why? |
| BCG Vaccine | 1 | 2021 | 1137 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.02 | Why? |
| Quality of Health Care | 1 | 2021 | 1948 | 0.02 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.02 | Why? |
| Multiple Myeloma | 1 | 2018 | 1064 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
| Immunization, Passive | 2 | 2020 | 10067 | 0.02 | Why? |
| Binding Sites | 1 | 2020 | 6201 | 0.02 | Why? |
| Symptom Assessment | 1 | 2021 | 4967 | 0.02 | Why? |
| Patient Acceptance of Health Care | 2 | 2017 | 5002 | 0.02 | Why? |
| Point-of-Care Systems | 1 | 2020 | 2955 | 0.02 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.02 | Why? |
| Proteomics | 1 | 2018 | 2481 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2020 | 3755 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2019 | 48226 | 0.02 | Why? |
| Animals | 2 | 2018 | 78931 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.02 | Why? |
| United States | 3 | 2020 | 46150 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Patient Compliance | 1 | 2014 | 1468 | 0.02 | Why? |
| Molecular Diagnostic Techniques | 1 | 2020 | 4239 | 0.02 | Why? |
| Viral Vaccines | 2 | 2020 | 7560 | 0.02 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.02 | Why? |
| Protein Binding | 1 | 2020 | 11430 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.02 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.02 | Why? |
| Herpesvirus 3, Human | 1 | 2004 | 228 | 0.01 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.01 | Why? |
| Sex Factors | 1 | 2019 | 11014 | 0.01 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2020 | 10649 | 0.01 | Why? |
| Travel | 1 | 2020 | 7220 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.01 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2017 | 7972 | 0.01 | Why? |
| Time-to-Treatment | 1 | 2017 | 5883 | 0.01 | Why? |
| Immune Sera | 1 | 2004 | 884 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Secondary Prevention | 1 | 2004 | 762 | 0.01 | Why? |
| Coinfection | 1 | 2019 | 6820 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Canada | 1 | 2011 | 6018 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Antineoplastic Agents | 1 | 2011 | 3550 | 0.01 | Why? |
| Practice Guidelines as Topic | 2 | 2012 | 15421 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.01 | Why? |
| Global Health | 1 | 2018 | 13911 | 0.01 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2004 | 9044 | 0.00 | Why? |
| Infection Control | 1 | 2007 | 23131 | 0.00 | Why? |